 Prostatic Neoplasms
"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
| Descriptor ID |
D011471
|
| MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
| Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 1 | 0 | 1 | | 1982 | 1 | 1 | 2 | | 1983 | 3 | 1 | 4 | | 1985 | 1 | 1 | 2 | | 1988 | 1 | 1 | 2 | | 1989 | 1 | 0 | 1 | | 1990 | 2 | 0 | 2 | | 1991 | 3 | 0 | 3 | | 1992 | 4 | 0 | 4 | | 1993 | 12 | 1 | 13 | | 1994 | 7 | 1 | 8 | | 1995 | 6 | 3 | 9 | | 1996 | 13 | 2 | 15 | | 1997 | 9 | 0 | 9 | | 1998 | 12 | 2 | 14 | | 1999 | 11 | 2 | 13 | | 2000 | 9 | 0 | 9 | | 2001 | 13 | 2 | 15 | | 2002 | 13 | 5 | 18 | | 2003 | 15 | 2 | 17 | | 2004 | 22 | 6 | 28 | | 2005 | 20 | 0 | 20 | | 2006 | 24 | 5 | 29 | | 2007 | 39 | 4 | 43 | | 2008 | 30 | 5 | 35 | | 2009 | 40 | 9 | 49 | | 2010 | 41 | 2 | 43 | | 2011 | 42 | 1 | 43 | | 2012 | 42 | 3 | 45 | | 2013 | 36 | 4 | 40 | | 2014 | 55 | 5 | 60 | | 2015 | 51 | 7 | 58 | | 2016 | 46 | 5 | 51 | | 2017 | 53 | 9 | 62 | | 2018 | 42 | 5 | 47 | | 2019 | 54 | 4 | 58 | | 2020 | 46 | 4 | 50 | | 2021 | 42 | 1 | 43 | | 2022 | 31 | 1 | 32 |
To return to the timeline, click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Kim DD, Daly AT, Koethe BC, Fendrick AM, Ollendorf DA, Wong JB, Neumann PJ. Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending. JAMA Netw Open. 2022 11 01; 5(11):e2243449.
-
Zhu Y, Koethe B, Ollendorf DA, Wong JB, Neumann PJ, Kim DD. Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage Population. Med Care. 2022 12 01; 60(12):888-894.
-
Lee GH, Chatterjee A, Karademir I, Engelmann R, Yousuf A, Giurcanu M, Harmath CB, Karczmar GS, Oto A. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI. Radiology. 2022 11; 305(2):399-407.
-
Gundogdu B, Pittman JM, Chatterjee A, Szasz T, Lee G, Giurcanu M, Medved M, Engelmann R, Guo X, Yousuf A, Antic T, Devaraj A, Fan X, Oto A, Karczmar GS. Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion. Magn Reson Med. 2022 11; 88(5):2298-2310.
-
Meza J, Babajide R, Saoud R, Sweis J, Abelleira J, Helenowski I, Jovanovic B, Eggener S, Miller FH, Horowitz JM, Casalino DD, Murphy AB. Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy naïve men across racial/ethnic groups. BMC Urol. 2022 Jul 18; 22(1):107.
-
Gupta N, Patel HD, Taylor J, Borin JF, Jacobsohn K, Kenfield SA, Eggener SE, Price C, Davuluri M, Byrne N, Bivalacqua TJ, Loeb S. Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes. Prostate Cancer Prostatic Dis. 2022 09; 25(3):444-452.
-
Lee J, Olivieri C, Ong C, Masterson LR, Gomes S, Lee BS, Schaefer F, Lorenz K, Veglia G, Rosner MR. Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop. Proc Natl Acad Sci U S A. 2022 06 21; 119(25):e2121867119.
-
Stenzl A, Szmulewitz RZ, Petrylak D, Holzbeierlein J, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Gomez-Veiga F, Ivanescu C, Rosbrook B, Ramaswamy K, Ganguli A, Haas GP, Armstrong AJ. The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups. Prostate. 2022 09; 82(13):1237-1247.
-
Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom C, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. Int J Radiat Oncol Biol Phys. 2022 10 01; 114(2):266-274.
-
Szasz T, Lee G, Chatterjee A, Medved M, Devaraj A, Yousuf A, Fan X, Karczmar GS, Oto A. Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging. Abdom Radiol (NY). 2022 07; 47(7):2500-2508.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|